#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15188	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2504	745.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1600	1600	C	932	C,T	931,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25612	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4029	792.6	0	.	n	.	0	T695C	SNP	695	695	T	1241	1241	C	885	C,A,T	881,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25612	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4029	792.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1883	1883	A	1089	A,C	1088,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25612	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4029	792.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2517	2517	C	810	C,A	808,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25612	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4029	792.6	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3143	3143	T	939	T,G	937,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25612	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4029	792.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2591	2591	A	792	A,C	791,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2148	folP	852	852	100.0	folP.l15.c4.ctg.1	1942	137.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1168	1170	AGC	205;204;202	A;G;C	205;204;202	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5398	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3888	173.2	1	SNP	p	S91F	0	.	.	271	273	TCC	826	828	TCC	185;185;187	T;C,A;C	185;184,1;187	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5398	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3888	173.2	1	SNP	p	D95G	0	.	.	283	285	GAC	838	840	GAC	193;192;192	G;A;C,A	193;192;191,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5398	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3888	173.2	1	SNP	p	D95N	0	.	.	283	285	GAC	838	840	GAC	193;192;192	G;A;C,A	193;192;191,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	2090	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1885	138.5	1	SNP	p	G45D	1	.	.	133	135	GAC	789	791	GAC	220;220;218	G,T;A;C	219,1;220;218	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1196	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	1377	107.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5228	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3530	184.7	1	SNP	p	D86N	0	.	.	256	258	GAC	808	810	GAC	243;244;244	G,T;A,C;C	242,1;243,1;244	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5228	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3530	184.7	1	SNP	p	S87W	0	.	.	259	261	AGT	811	813	AGT	241;241;242	A,C;G;T	239,2;241;242	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5228	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3530	184.7	1	SNP	p	S87I	0	.	.	259	261	AGT	811	813	AGT	241;241;242	A,C;G;T	239,2;241;242	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5228	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3530	184.7	1	SNP	p	S87R	0	.	.	259	261	AGT	811	813	AGT	241;241;242	A,C;G;T	239,2;241;242	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5228	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3530	184.7	1	SNP	p	S88P	0	.	.	262	264	TCC	814	816	TCC	242;244;244	T;C;C	242;244;244	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4426	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3171	174.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1827	1829	GGC	264;264;262	G;G,T;C	264;262,2;262	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2946	178.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1565	1567	GCA	278;277;272	G;C;A	278;277;272	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2946	178.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1568	1570	ATC	272;269;270	A;T,G;C,A	272;267,2;269,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2946	178.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1580	1582	GTG	270;268;270	G,C;T;G,T	269,1;268;269,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2946	178.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1580	1582	GTG	270;268;270	G,C;T;G,T	269,1;268;269,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2946	178.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2084	2086	ACC	216;217;215	A;C;C,A	216;217;214,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2946	178.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2138	2140	GCG	222;224;224	G;C;G,T,C	222;224;222,1,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2946	178.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2138	2140	GCG	222;224;224	G;C;G,T,C	222;224;222,1,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2946	178.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2261	2263	GGC	233;233;228	G,C;G;C,A	232,1;233;227,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2946	178.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2270	2272	GGC	227;227;230	G;G;C	227;227;230	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4208	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2946	178.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2288	2290	CCG	235;239;239	C,G,A;C;G,T	233,1,1;239;238,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5846	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3579	203.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1841	1843	CTG	238;239;239	C;T;G	238;239;239	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2652	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2314	143.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	868	868	C	202	C,T	201,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	284	porB1a	984	319	90.12	porB1a.l6.c30.ctg.1	825	21.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	530	532	AAT	3;3;3	A;A;T	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	284	porB1a	984	319	90.12	porB1a.l6.c30.ctg.1	825	21.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	533	535	AAT	3;3;3	A;A;T	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	284	porB1a	984	319	90.12	porB1a.l6.c30.ctg.1	825	21.3	0	.	p	.	0	A222V	NONSYN	664	666	GCT	545	547	GTT	1;1;1	G;T;T	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	284	porB1a	984	319	90.12	porB1a.l6.c30.ctg.1	825	21.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	557	559	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	284	porB1a	984	319	90.12	porB1a.l6.c30.ctg.1	825	21.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	580	582	GTA	2;2;2	G;T;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	284	porB1a	984	319	90.12	porB1a.l6.c30.ctg.1	825	21.3	0	.	p	.	0	N237fs	FSHIFT	709	709	A	589	589	A	2	A	2	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	G38E	NONSYN	112	114	GGA	711	713	GAA	264;262;258	G;A,C;A	264;259,3;258	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	S46G	NONSYN	136	138	AGC	735	737	GGC	254;252;252	G,A;GCGT,G;C,A	253,1;250,1;251,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	E48G	NONSYN	142	144	GAA	741	743	GGA	247;246;252	G,T;G,C;A	244,1;243,1;252	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	T87A	NONSYN	259	261	ACT	858	860	GCT	223;221;222	G;C;T	223;221;222	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	T89S	NONSYN	265	267	ACC	864	866	AGC	215;216;218	A,G;G;C	214,1;216;218	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	.	MULTIPLE	358	359	AA	956	957	CG	202;203	C;G,T	202;202,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	.	MULTIPLE	361	362	GA	959	961	CAG	205;206;207	C;A;G	205;206;207	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	N122K	NONSYN	364	366	AAC	963	965	AAA	208;209;209	A;A;A	208;209;209	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	K143E	NONSYN	427	429	AAA	1026	1028	GAA	249;248;248	G;A;A	249;248;248	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	1050	1052	GCA	253;257;255	G;C;A	253;257;255	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1242	1244	ACT	238;237;239	A;C;T,G,A	238;237;237,1,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1251	1253	ATG	234;234;234	A;T;G	234;234;234	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1365	1367	GCA	214;213;211	G;C;A	214;213;211	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1368	1370	ACG	213;212;220	A;C,T;G,A	213;211,1;219,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	S258G	NONSYN	772	774	AGT	1371	1373	GGG	220;222;222	G,T;G,T;G	219,1;221,1;222	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1374	1376	GTT	222;219;219	G;T,G;T	222;218,1;219	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1434	1436	GTA	253;251;253	G;T;A	253;251;253	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1473	1475	ACT	246;248;244	A;C;T	246;248;244	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1479	1481	GAT	248;250;250	G;A;T	248;250;250	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1491	1493	CAC	259;261;262	C;A;C,A	259;261;261,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	1	SNP	p	G120K	1	.	.	358	360	AAG	956	958	CGG	202;203;204	C;G,T;G	202;202,1;204	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	1	SNP	p	D121N	0	.	.	361	363	GAC	959	962	CGC	205;207;205	C;G;C	205;207;205	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2782	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1816	188.9	1	SNP	p	A121D	1	.	.	361	363	GAC	959	962	CGC	205;207;205	C;G;C	205;207;205	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9650	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	5468	220.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2299	2301	AAT	238;237;236	A;A;T	238;237;236	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1418	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1337	130.9	1	SNP	p	V57M	1	.	.	169	171	ATG	679	681	ATG	256;259;258	A;T;G,C	256;259;257,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
